Alector ALEC
NASDAQ ALEC
$2.46 -0.05 (-1.99%)
At close: Sep 4, 2026 · 4:00 PM EDT

Alector (ALEC) Short-term Investments (2018 - 2026)

Alector's (ALEC) quarterly Short-term Investments came in at $112.9 million in Q2 2026, down 57.0% year-over-year from $262.5 million in Q2 2025, and down 12.87% quarter-over-quarter from $129.6 million in Q1 2026.

Analysis

Alector (ALEC) Short-term Investments (2018 - 2026) Analysis & Trends

Alector (ALEC) has reported Short-term Investments for 9 consecutive years, with $112.9 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Short-term Investments fell 57.0% year-over-year to $112.9 million in Q2 2026; TTM through Jun 2026 was $112.9 million, a 57.0% decrease from a year earlier, with the FY2025 full-year figure at $190.2 million, down 49.99% from the prior year.
  • Short-term Investments was $112.9 million for Q2 2026 at Alector, down from $129.6 million in the prior quarter.
  • Over five years, Short-term Investments peaked at $636.6 million in Q2 2022 and troughed at $112.9 million in Q2 2026.
  • A 5-year average of $393.8 million and a median of $437.9 million in 2024 frame the typical range for Short-term Investments.
  • Across the five-year window, Short-term Investments soared 228.38% in 2022 and tumbled 59.08% in 2026, its largest moves.
  • Over 5 years, Short-term Investments stood at $558.5 million in 2022, then slipped by 15.08% to $474.3 million in 2023, then declined by 19.8% to $380.4 million in 2024, then slumped by 49.99% to $190.2 million in 2025, then slumped by 40.66% to $112.9 million in 2026.
  • The last three Short-term Investments figures came in at $112.9 million (Q2 2026), $129.6 million (Q1 2026), and $190.2 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn
10 Alector 274.68 Mn 101.88 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 112.88 Mn
Mar 31, 2026 129.55 Mn
Dec 31, 2025 190.22 Mn
Sep 30, 2025 214.61 Mn
Jun 30, 2025 262.51 Mn
Mar 31, 2025 316.58 Mn
Dec 31, 2024 380.38 Mn
Sep 30, 2024 420.04 Mn
Jun 30, 2024 455.79 Mn
Mar 31, 2024 489.53 Mn
Dec 31, 2023 474.31 Mn
Sep 30, 2023 486.90 Mn
Jun 30, 2023 498.51 Mn
Mar 31, 2023 473.77 Mn
Dec 31, 2022 558.53 Mn
Sep 30, 2022 574.08 Mn
Jun 30, 2022 636.59 Mn
Mar 31, 2022 413.95 Mn
Dec 31, 2021 406.10 Mn
Sep 30, 2021 261.32 Mn